Legal & General Group Plc raised its position in Neogen Co. (NASDAQ:NEOG) by 2.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 75,156 shares of the company’s stock after purchasing an additional 1,971 shares during the quarter. Legal & General Group Plc owned 0.20% of Neogen worth $5,820,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the company. American International Group Inc. raised its position in shares of Neogen by 5.7% during the third quarter. American International Group Inc. now owns 29,523 shares of the company’s stock worth $2,287,000 after acquiring an additional 1,601 shares during the last quarter. Wasatch Advisors Inc. bought a new position in shares of Neogen during the third quarter worth about $11,016,000. Ameriprise Financial Inc. raised its position in shares of Neogen by 9.2% during the third quarter. Ameriprise Financial Inc. now owns 406,464 shares of the company’s stock worth $31,486,000 after acquiring an additional 34,188 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Neogen by 728.7% during the third quarter. SG Americas Securities LLC now owns 18,431 shares of the company’s stock worth $1,428,000 after acquiring an additional 16,207 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of Neogen by 4.5% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 25,764 shares of the company’s stock worth $1,996,000 after acquiring an additional 1,109 shares during the last quarter. Institutional investors own 87.06% of the company’s stock.
Neogen Co. (NASDAQ NEOG) opened at $81.42 on Friday. Neogen Co. has a 1 year low of $59.51 and a 1 year high of $85.89. The stock has a market capitalization of $3,041.63, a PE ratio of 66.91, a PEG ratio of 4.05 and a beta of 1.54.
Neogen (NASDAQ:NEOG) last released its earnings results on Tuesday, September 19th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.30 by $0.01. Neogen had a return on equity of 9.93% and a net margin of 12.28%. The business had revenue of $95.30 million during the quarter, compared to analysts’ expectations of $94.87 million. During the same quarter last year, the firm posted $0.26 earnings per share. The firm’s revenue was up 14.0% on a year-over-year basis. equities analysts forecast that Neogen Co. will post 1.31 EPS for the current fiscal year.
In related news, VP Edward Bradley sold 17,824 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $80.32, for a total transaction of $1,431,623.68. Following the completion of the sale, the vice president now owns 27,212 shares of the company’s stock, valued at $2,185,667.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Steven J. Quinlan sold 2,772 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $73.54, for a total value of $203,852.88. Following the sale, the chief financial officer now directly owns 12,875 shares of the company’s stock, valued at approximately $946,827.50. The disclosure for this sale can be found here. Insiders have sold 173,034 shares of company stock valued at $13,316,509 in the last ninety days. 4.20% of the stock is currently owned by insiders.
A number of equities analysts have recently issued reports on NEOG shares. Zacks Investment Research upgraded Neogen from a “hold” rating to a “buy” rating and set a $93.00 price objective for the company in a research report on Wednesday, November 29th. Craig Hallum raised their price objective on Neogen from $62.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, December 7th. Finally, Roth Capital started coverage on Neogen in a research report on Tuesday, December 5th. They set a “neutral” rating and a $82.00 price objective for the company. Five analysts have rated the stock with a hold rating, The stock currently has a consensus rating of “Hold” and an average price target of $85.00.
TRADEMARK VIOLATION WARNING: This piece of content was posted by Week Herald and is the property of of Week Herald. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://weekherald.com/2017/12/17/legal-general-group-plc-boosts-holdings-in-neogen-co-neog.html.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.